FDA Drug recall D-0116-2017
Desoximetasone Cream USP, 0.25% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc
- FDA Drug
- Class II
- terminated
- Published 2016-11-09
On 2016-11-09 the FDA classified a Class II recall of Desoximetasone Cream USP, 0.25% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc by Taro Pharmaceuticals, citing failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0116-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-09-13 |
| Published | 2016-11-09 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Taro Pharmaceuticals |
| Distribution | PR |
Product
Desoximetasone Cream USP, 0.25% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1270-7
Reason
Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).
Identifiers
| ndc | 51672-1271-1 |
|---|---|
| ndc | 51672-1271-2 |
| ndc | 51672-1271-3 |
| ndc | 51672-1271-7 |
| ndc | 51672-1270-1 |
| ndc | 51672-1270-2 |
| ndc | 51672-1270-3 |
| ndc | 51672-1270-7 |
| ndc | 51672-1261-1 |
| ndc | 51672-1261-2 |
| ndc | 51672-1261-3 |
| code_info | Lot #: B5093-18608, B5094-18608, Exp. Jan 2017; Lot #: C5141-18954, C5142-18954, E5109-19625, Exp . Feb 2017 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0116-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.